Institutional Ownership
Avadel Pharmaceuticals PLC
CUSIP 05337M104COMMON STOCK-FOQ1 2026
13D / 13G Filings
33
Schedule 13D/13G on record
Beneficial Filers
12
Distinct reporting persons
Largest Stake
12.4%
Max % of class reported
Institutional Holders
1
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
33 filings · latest Feb 6, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 6, 2026 | Tontine Asset Associates, LLC | 13G/A | 4.9% | 4.84M | SEC |
| 2 | Nov 14, 2024 | Rtw Investments, LP | 13G/A | — | — | SEC |
| 3 | Nov 13, 2024 | Polar Capital Holdings PLC | 13G/A | 5.0% | 4.80M | SEC |
| 4 | Nov 13, 2024 | Cowen And Company, LLC | 13G/A | — | — | SEC |
| 5 | Feb 14, 2024 | Rtw Investments, LP | 13G/A | 10.0% | 9.20M | SEC |
| 6 | Feb 13, 2024 | Janus Henderson Group PLC | 13G/A | 12.4% | 11.13M | SEC |
| 7 | Feb 13, 2024 | Gendell Jeffrey L | 13G/A | 3.9% | 3.54M | SEC |
| 8 | Feb 13, 2024 | Polar Capital Holdings PLC | 13G | 7.5% | 6.75M | SEC |
| 9 | Feb 12, 2024 | Kotler Kevin | 13G/A | 4.1% | 3.72M | SEC |
| 10 | Aug 10, 2023 | Janus Henderson Group PLC | 13G | 12.3% | 9.44M | SEC |
23 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Avadel Pharmaceuticals PLC.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Huntington National Bank | 1 | $16 |